Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear factor erythroid 2-like 1 (NFE2L1, often referred to as Nrf1 or TCF11) is a member of the CNC-bZIP family of transcription factors, ubiquitously expressed and essential for regulating cellular homeostasis[1][2][5]. It anchors to the endoplasmic reticulum membrane until stress signals induce its proteolytic processing and nuclear translocation, where it activates genes involved in oxidative stress defense, protein degradation (proteasome subunits), and lipid metabolism[1][3][5]. NFE2L1 maintains cell viability by safeguarding proteostasis and modulating the antioxidant response, supporting functions in development, tissue regeneration, cancer prevention, bone remodeling, and neuroprotection[2][3][5]. Loss of NFE2L1 function results in severe phenotypes, including embryonic lethality and susceptibility to neurodegeneration or liver tumorigenesis in animal models[5]. Unlike membrane-bound receptors or enzymes, NFE2L1 acts in the nucleus as a master regulator of cellular adaptive programs[1][2][3][5].
Activation of antioxidant response element (ARE)–dependent genes to induce cytoprotective programs; Induction of proteasome subunit genes to restore proteasome activity under stress
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear factor erythroid 2-like 1 (NFE2L1).